| IDEXX LABS INC. DL-,10 |
| USA |
| Gesundheit |
| US45168D1046 / 888210 |
| IX1 (Frankfurt) / IDXX (NASDAQ) |
| FRA:IX1, ETR:IX1, IX1:GR, NASDAQ:IDXX |
| https://www.idexx.com/ |
|
IDEXX Laboratories, Inc. is a global leader in the..
>Volltext.. |
| 43651.28 Mio. EUR |
| 44564.21 Mio. EUR |
| 3499.57 Mio. EUR |
| 1206.47 Mio. EUR |
| 854.29 Mio. EUR |
| 10.5 EUR |
| 1072.37 Mio. EUR |
| 142.66 Mio. EUR |
| 785.08 Mio. EUR |
| 0.13 |
| -3% |
| 5.98% |
| - |
| - |
| - |
| - |
| IDEXX |
| 03.11.25 |